The urinary tract infection (UTI) treatment market was valued at USD 11.5 billion in 2025, is projected to reach USD 13.9 billion by 2035 and is forecast to register a 1.9% CAGR between 2025 and 2035. In 2025, quinolones hold 45.7% of the drug class category and uncomplicated UTIs represents 70% of indication demand.